R. Wilkinson

1.9k total citations · 1 hit paper
53 papers, 1.3k citations indexed

About

R. Wilkinson is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, R. Wilkinson has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 11 papers in Nephrology and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in R. Wilkinson's work include Renal and Vascular Pathologies (7 papers), Organ Donation and Transplantation (5 papers) and Thyroid Disorders and Treatments (5 papers). R. Wilkinson is often cited by papers focused on Renal and Vascular Pathologies (7 papers), Organ Donation and Transplantation (5 papers) and Thyroid Disorders and Treatments (5 papers). R. Wilkinson collaborates with scholars based in United Kingdom, United States and Singapore. R. Wilkinson's co-authors include B. E. C. Nordin, John C. Gallagher, D.H. Marshall, A. Horsman, J. Aaron, Munro Peacock, A. Hodgkinson, PA Rutherford, T. H. Thomas and M. K. Ward and has published in prestigious journals such as The Lancet, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

R. Wilkinson

49 papers receiving 1.2k citations

Hit Papers

EFFECT OF AGE ON CALCIUM ABSORPTION 1970 2026 1988 2007 1970 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Wilkinson United Kingdom 21 310 296 277 214 205 53 1.3k
Anna Challa Greece 22 149 0.5× 440 1.5× 162 0.6× 139 0.6× 207 1.0× 79 1.4k
G Stein Germany 22 142 0.5× 200 0.7× 105 0.4× 218 1.0× 167 0.8× 68 1.3k
J. Lemann United States 21 171 0.6× 276 0.9× 503 1.8× 331 1.5× 166 0.8× 33 2.0k
K. Schaefer Germany 18 121 0.4× 376 1.3× 115 0.4× 128 0.6× 140 0.7× 95 1.3k
Elisabeth Ryzen United States 18 172 0.6× 343 1.2× 278 1.0× 78 0.4× 165 0.8× 25 1.4k
H. E. Meema Canada 19 445 1.4× 114 0.4× 87 0.3× 106 0.5× 118 0.6× 42 1.0k
G. A. Lumb United Kingdom 24 357 1.2× 1.1k 3.9× 276 1.0× 211 1.0× 270 1.3× 36 2.2k
Ashok K. Bhalla United Kingdom 10 265 0.9× 579 2.0× 70 0.3× 268 1.3× 458 2.2× 16 1.7k
Mordecai M. Popovtzer United States 19 59 0.2× 179 0.6× 317 1.1× 209 1.0× 127 0.6× 69 1.6k
Helle Frost Andreassen Denmark 13 271 0.9× 163 0.6× 144 0.5× 163 0.8× 73 0.4× 24 862

Countries citing papers authored by R. Wilkinson

Since Specialization
Citations

This map shows the geographic impact of R. Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Wilkinson more than expected).

Fields of papers citing papers by R. Wilkinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Wilkinson. The network helps show where R. Wilkinson may publish in the future.

Co-authorship network of co-authors of R. Wilkinson

This figure shows the co-authorship network connecting the top 25 collaborators of R. Wilkinson. A scholar is included among the top collaborators of R. Wilkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Wilkinson. R. Wilkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilkinson, R.. (2009). Discussing inherited medical conditions in border collies.. 39(18). 26–29.
2.
Zuraw, Bruce L., Paula J. Busse, Martha V. White, et al.. (2008). Efficacy and Safety of Long-Term Prophylaxis with C1 Inhibitor (C1INH) Concentrate in Patients with Hereditary Angioedema (HAE). Journal of Allergy and Clinical Immunology. 121(2). S272–S272. 4 indexed citations
3.
Hawkins, T, et al.. (1994). Thallium-technetium-subtraction scintigraphy in secondary hyperparathyroidism. European Journal of Nuclear Medicine and Molecular Imaging. 21(6). 509–13. 15 indexed citations
4.
Harrison, Kathleen A., et al.. (1992). Reduced erythrocyte and leukocyte magnesium is associated with cyclosporin treatment and hypertension in renal transplant patients. Nephrology Dialysis Transplantation. 7(3). 251–255. 22 indexed citations
5.
Svetkey, Laura P., et al.. (1991). Captopril Renography in the Diagnosis of Renovascular Disease. American Journal of Hypertension. 4(12 Pt 2). 711S–715S. 15 indexed citations
6.
Heseltine, D., et al.. (1990). Potassium Supplementation in the Treatment of Idiopathic Postural Hypotension. Age and Ageing. 19(6). 409–414. 8 indexed citations
7.
Wilkinson, R. & Soheir S. Mansy. (1990). A Dose Finding Study of the Combination of Atenolol and Nifedipine in Hypertension. Current Medical Research and Opinion. 12(2). 108–113. 3 indexed citations
8.
Main, John & R. Wilkinson. (1989). Early renal artery occlusion after enalapril in atheromatous renal artery stenosis.. BMJ. 299(6695). 394.2–394. 4 indexed citations
9.
Leung, Donald Y.M., L. Lyndon Key, Jacob J. Steinberg, et al.. (1988). Increased in vitro bone resorption by monocytes in the hyper-immunoglobulin E syndrome.. The Journal of Immunology. 140(1). 84–88. 40 indexed citations
10.
Tapson, J.S., Alan W. Hodson, S. M. Marshall, & R. Wilkinson. (1988). Urinary Enzyme Excretion after Donor Nephrectomy. ˜The œNephron journals/Nephron journals. 48(2). 126–131. 6 indexed citations
11.
Franklyn, JA, Martin R. Wilkins, R. Wilkinson, D. Ramsden, & Michael C. Sheppard. (1985). The effect of propranolol on circulating thyroid hormone measurements in thyrotoxic and euthyroid subjects. European Journal of Endocrinology. 108(3). 351–355. 11 indexed citations
12.
Sellars, L, K. C. Siamopoulos, P.M. Hacking, et al.. (1985). Renovascular Hypertension: Ten Years' Experience in a Regional Centre. QJM. 56(219). 403–16. 4 indexed citations
13.
Wilkinson, R., et al.. (1984). β-Blockade and Serum Triiodothyronine. Clinical Science. 66(6). 19P.1–19P. 1 indexed citations
14.
Wilkinson, R., J. A. Franklyn, M C Sheppard, & D. Ramsden. (1984). β-Blockade and Serum Triiodothyronine. Clinical Science. 66(2). 19P–19P. 1 indexed citations
15.
Wilkinson, R.. (1983). Beta blockade in the management of thyrotoxicosis.. PubMed. 8(4). 323–32. 1 indexed citations
16.
Wilkinson, R., et al.. (1982). The effects of cimetidine on serum calcium and parathyroid hormone levels in primary hyperparathyroidism.. British Journal of Clinical Pharmacology. 14(5). 701–705. 8 indexed citations
17.
Jachuck, S J & R. Wilkinson. (1973). Abdominal Bruit after Renal Transplantation. BMJ. 3(5873). 202–203. 4 indexed citations
18.
Wilkinson, R., et al.. (1972). Growth-hormone deficiency in iatrogenic hypothyroidism.. BMJ. 2(5805). 87–88. 3 indexed citations
19.
Burton, J.L., et al.. (1972). Sebum Excretion in Acromegaly. BMJ. 1(5797). 406–408. 39 indexed citations
20.
Wilkinson, R., John A. Luetscher, & Robert H. Goldman. (1971). Serum enzymes and propranolol.. BMJ. 2(5756). 276.4–277. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026